Grail Inc GRAL
$68.56
▼ -3.63%
($-2.58)
🎢 High Beta
🗓️ Earnings Next Week
Open
$71.50
Prev Close
$71.14
Day Range
$67.16 – $71.57
52W Range
$29.95 – $118.84
Market Cap
$2.94B
Beta
2.21
EPS (TTM)
$-10.37
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-06-12 |
| Shares Out. | 42,920,000 |
| Website | grail.com/ ↗ |
| Phone | 13026587581 |
| Employees | 910 |
| Revenue | $40.8M |
| Gross Profit | -$14.3M |
| Net Income | -$93.2M |
| Free Cash Flow | -$292.3M |
| Total Assets | $2.80B |
| Total Liabilities | $302.8M |
| Equity | $2.50B |
About Grail Inc
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Grail Inc is a publicly traded company under the ticker symbol GRAL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-07-01)